A detailed history of Evergreen Capital Management LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Evergreen Capital Management LLC holds 3,824 shares of JAZZ stock, worth $473,258. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,824
Previous 2,843 34.51%
Holding current value
$473,258
Previous $303,000 40.59%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $98,659 - $114,158
981 Added 34.51%
3,824 $426,000
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $1.54 Million - $1.76 Million
-14,815 Reduced 83.9%
2,843 $303,000
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $42,850 - $49,390
372 Added 2.15%
17,658 $2.13 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $132,998 - $158,304
-1,164 Reduced 6.31%
17,286 $2.13 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $59,902 - $71,347
491 Added 2.73%
18,450 $2.39 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $39,200 - $47,091
320 Added 1.81%
17,959 $2.23 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $28,537 - $34,180
-213 Reduced 1.19%
17,639 $2.58 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $54,871 - $67,616
-423 Reduced 2.31%
17,852 $2.84 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $33,166 - $42,229
-262 Reduced 1.41%
18,275 $2.44 Million
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $124,174 - $147,914
-877 Reduced 4.52%
18,537 $2.89 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $18,538 - $22,980
-143 Reduced 0.73%
19,414 $3.02 Million
Q4 2021

Mar 11, 2022

BUY
$119.87 - $145.67 $259,398 - $315,229
2,164 Added 12.44%
19,557 $2.49 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $2.24 Million - $3.21 Million
17,393 New
17,393 $2.27 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.76B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.